Faropenem Catalog No.:M16831-C TGX221 is a selective inhibitor

TGX221 is a selective inhibitor for ccRCC with both VHL and SETD2 mutations

and B-cells and related inflammatory responses and tissue damage

Krumbach R

Formula: C50H88N14O15

5 with Kis of 230 and 605 μM

Faropenem Catalog No.:M16831-C TGX221 is a selective inhibitorFaropenem is a potent and orally active beta lactam antibiotic. Faropenem demonstrates broad spectrum in vitro antimicrobial activity against many gram positive and negative aerobes and anaerobes. Faropenem is resistant to hydrolysis by nearly all beta lactamases, including extended spectrum beta lactamases and AmpC beta lactamases. Faropenem is developed as an oral prodrug, faropenem medoxomil, for the research of respiratory tract infections.